Comparison of a New Triazole Antifungal Agent, Schering 56592, with Itraconazole and Amphotericin B for Treatment of Histoplasmosis in Immunocompetent Mice

A murine model of intratracheally induced histoplasmosis was used to evaluate a new triazole antifungal agent, Schering (SCH) 56592, for treatment of histoplasmosis. MICs were determined for SCH 56592, amphotericin B, and itraconazole by testing yeast-phase isolates from 20 patients by a macrobroth...

Полное описание

Библиографические подробности

Опубликовано в::	Antimicrob Agents Chemother
Главные авторы:	Connolly, Patricia, Wheat, Joe, Schnizlein-Bick, Carol, Durkin, Michelle, Kohler, Steve, Smedema, Melinda, Goldberg, Janet, Brizendine, Edward, Loebenberg, David
Формат:	Artigo
Язык:	Inglês
Опубликовано:	American Society for Microbiology (ASM) 1999
Предметы:	Experimental Therapeutics
Online-ссылка:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89071/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9925526/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.2.322
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!